IDEXX Laboratories Inc (IDXX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has a cash flow conversion efficiency ratio of 0.171x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($266.25 Million) by net assets ($1.56 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IDXX net asset quality index to measure how much of total assets are equity-financed.
IDEXX Laboratories Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IDEXX Laboratories Inc (IDXX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
IDEXX Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IDEXX Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Old Dominion Freight Line Inc
NASDAQ:ODFL
|
0.085x |
|
STMicroelectronics N.V
F:SGMR
|
0.029x |
|
Itau Unibanco Banco Holding SA
NYSE:ITUB
|
-0.024x |
|
Itaú Unibanco Holding S.A
F:BVXB
|
-0.202x |
|
Rocket Lab USA Inc.
NASDAQ:RKLB
|
-0.022x |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
0.116x |
|
Goodman Group
AU:GMG
|
0.025x |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
0.049x |
Annual Cash Flow Conversion Efficiency for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see IDEXX Laboratories Inc (IDXX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.61 Billion | $1.18 Billion | 0.734x | +26.01% |
| 2024-12-31 | $1.60 Billion | $929.00 Million | 0.582x | -4.64% |
| 2023-12-31 | $1.48 Billion | $906.51 Million | 0.611x | -31.54% |
| 2022-12-31 | $608.74 Million | $542.98 Million | 0.892x | -18.54% |
| 2021-12-31 | $689.99 Million | $755.55 Million | 1.095x | +6.92% |
| 2020-12-31 | $632.79 Million | $648.06 Million | 1.024x | -60.34% |
| 2019-12-31 | $177.82 Million | $459.16 Million | 2.582x | +105.96% |
| 2018-12-31 | $-9.23 Million | $400.08 Million | -43.332x | -525.03% |
| 2017-12-31 | $-53.84 Million | $373.28 Million | -6.933x | -124.23% |
| 2016-12-31 | $-108.21 Million | $334.57 Million | -3.092x | -20.03% |
| 2015-12-31 | $-84.00 Million | $216.36 Million | -2.576x | -228.43% |
| 2014-12-31 | $117.59 Million | $235.85 Million | 2.006x | +322.52% |
| 2013-12-31 | $518.21 Million | $246.00 Million | 0.475x | +31.16% |
| 2012-12-31 | $636.26 Million | $230.28 Million | 0.362x | -11.51% |
| 2011-12-31 | $539.59 Million | $220.70 Million | 0.409x | +31.34% |
| 2010-12-31 | $574.28 Million | $178.83 Million | 0.311x | -7.76% |
| 2009-12-31 | $514.58 Million | $173.72 Million | 0.338x | +3.20% |
| 2008-12-31 | $438.19 Million | $143.34 Million | 0.327x | +6.11% |
| 2007-12-31 | $438.32 Million | $135.12 Million | 0.308x | +15.05% |
| 2006-12-31 | $409.86 Million | $109.83 Million | 0.268x | -15.09% |
| 2005-12-31 | $369.31 Million | $116.55 Million | 0.316x | +31.58% |
| 2004-12-31 | $397.66 Million | $95.38 Million | 0.240x | -15.39% |
| 2003-12-31 | $413.29 Million | $117.16 Million | 0.283x | -6.39% |
| 2002-12-31 | $340.97 Million | $103.25 Million | 0.303x | +97.07% |
| 2001-12-31 | $301.73 Million | $46.36 Million | 0.154x | +42.42% |
| 2000-12-31 | $261.75 Million | $28.24 Million | 0.108x | -41.69% |
| 1999-12-31 | $284.30 Million | $52.60 Million | 0.185x | +23.53% |
| 1998-12-31 | $307.80 Million | $46.10 Million | 0.150x | +235.82% |
| 1997-12-31 | $302.70 Million | $13.50 Million | 0.045x | +79.90% |
| 1996-12-31 | $322.70 Million | $8.00 Million | 0.025x | +1.75% |
| 1995-12-31 | $279.10 Million | $6.80 Million | 0.024x | -83.57% |
| 1994-12-31 | $99.80 Million | $14.80 Million | 0.148x | +67.54% |
| 1993-12-31 | $83.60 Million | $7.40 Million | 0.089x | +6331.58% |
| 1992-12-31 | $70.40 Million | $-100.00K | -0.001x | -101.18% |
| 1991-12-31 | $31.50 Million | $3.80 Million | 0.121x | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more